Office of the Assistant Secretary for Health; Opportunity To Co-Sponsor OASH-Supported Grantee Workshops, 70848-70849 [2022-25259]
Download as PDF
<![CDATA[
lotter on DSK11XQN23PROD with NOTICES1
70848
Federal Register / Vol. 87, No. 223 / Monday, November 21, 2022 / Notices
• TBDWG 2018 7.7b Testing and
Diagnostic Bands: How They Are Used
Today and What That Is Doing to
Patients: Engage Diverse Stakeholders—
Update the CSTE Surveillance Case
Definition with 21st-Century Evidence
• TBDWG 2020 3.1 Implement multiagency, ecologically-based One Health
efforts on tick-borne diseases promoting
research and enhanced vector
surveillance to identify and validate
integrated tick management in keystone
wildlife hosts, particularly white-tailed
deer, and the sustainable management
of their populations.
• TBDWG 2020 8.2 Recommend that
CDC work with Council of State and
Territorial Epidemiologists (CSTE) to
streamline the surveillance process and
to reduce the burden on both clinicians
and public health departments by
permitting direct laboratory reporting of
positive cases.
Strategic Priority 4: Respond to Public
Health emergencies resulting from VBD
threats.
Strategic Priority 5: Clarify, facilitate,
and improve processes to bring
regulated diagnostic tests, treatment
strategies, vaccines, and vector control
products to market.
Although critical to public health and
wellness, the following
recommendations related to healthcare
utilization, access to care,
reimbursement or payment for clinical
services, and legal protections are
outside the scope of this prevention and
control strategy:
• TBDWG 2018 3.3 Support economic
studies and activities to estimate the
total cost of illness associated with tickborne diseases in the United States,
beginning first with Lyme disease and
including both financial and societal
impacts.
• TBDWG 2018 7.3 Ensure the rights
of those dealing with Lyme disease and
tick-borne diseases and conditions by
reducing the burden of the processes
under which patients are currently
diagnosed and treated and by which
they access care. Basic protections must
include, but not necessarily be limited
to, those that protect patients from
employment discrimination.
• TBDWG 2018 7.4 Ensure the rights
of those dealing with Lyme disease and
tick-borne diseases and conditions by
reducing the burden of the processes
under which patients are currently
diagnosed and treated and by which
they access care. Basic protections must
include, but not necessarily be limited
to, those that protect students of all ages
from discrimination.
• TBDWG 2018 7.5 Ensure the rights
of those dealing with Lyme disease and
tick-borne diseases and conditions by
VerDate Sep<11>2014
21:25 Nov 18, 2022
Jkt 259001
reducing the burden of the processes
under which patients are currently
diagnosed and treated and by which
they access care. Basic protections must
include, but not necessarily be limited
to, those that protect patients from
health care and disability insurance
coverage and reimbursement policies
that are unduly burdensome.
• TBDWG 2018 7.6 Ensure the rights
of those dealing with Lyme disease and
tick-borne diseases and conditions by
reducing the burden of the processes
under which patients are currently
diagnosed and treated and by which
they access care. Basic protections must
include, but not necessarily be limited
to, those that protect the rights of
licensed and qualified clinicians to use
individual clinical judgment, as well as
recognized guidelines, to diagnose and
treat patients in accordance with the
needs and goals of each individual
patient.
• TBDWG 2020 9.6 CMS:
Recommend that CMS provides all
information and data on Lyme disease
and other tick-borne diseases and all
applicable agency activities pertaining
to these conditions which may include
but should not be limited to:
Æ Reimbursement costs for the
diagnosis and treatment of beneficiaries
with Lyme disease and other tick-borne
diseases;
Æ Demonstration and pilot projects
with Lyme disease and other tick-borne
diseases as their focus; and
Æ Quality measure development and
implementation related to Lyme disease
and other tick-borne diseases.
[FR Doc. 2022–25241 Filed 11–18–22; 8:45 am]
BILLING CODE 4150–28–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the Assistant Secretary for
Health; Opportunity To Co-Sponsor
OASH-Supported Grantee Workshops
Office of the Assistant
Secretary for Health, HHS.
ACTION: Notice.
AGENCY:
The Grants and Acquisitions
Management Division (GAM) in the
Office of the Assistant Secretary for
Health (OASH), in conjunction with the
grant making program offices it
supports, announces the opportunity for
non-federal public and private sector
entities to co-sponsor OASH-supported
grants workshops (OASH Grants
Workshops). Potential co-sponsors must
have a demonstrated interest and
experience in building capacity among
potential grant applicants and grant
SUMMARY:
PO 00000
Frm 00079
Fmt 4703
Sfmt 4703
recipients. Potential co-sponsors must
be willing to participate substantively in
the co-sponsored activity. Expressions
of interest for co-sponsorships of OASH
Grants Workshops are received
throughout the year at the email address
below. OASH intends to co-sponsor a
limited number of workshops with other
entities each year. Expressions of
interest are being received for OASH
Grants Workshops that will take place
in the next fiscal year (October 2022
through September 2023) or beyond.
Expressions of interest for cosponsorships should be sent by email to
OASH_Grants@HHS.GOV with ‘‘Cosponsorship for OASH-supported Grants
Workshops’’ in the subject field or by
mail to Duane Barlow, Grants Branch
Chief, OASH, Grants and Acquisitions
Management Division, at 1101 Wootton
Parkway, Plaza Level, Rockville, MD
20852.
FOR FURTHER INFORMATION CONTACT:
Duane Barlow, Grants Branch Chief,
OASH, Grants and Acquisitions
Management Division, 1101 Wootton
Parkway, Plaza Level, Rockville, MD
20852; or via phone (240) 453–8822.
SUPPLEMENTARY INFORMATION: The
OASH Grants and Acquisitions
Management (GAM) Division oversees,
administers, and supports grant-making
activities of public health offices on
behalf of the Secretary of the U.S.
Department of Health and Human
Services (HHS). The grant-making
program offices that GAM supports
include: the Office of Infectious Disease
and HIV/AIDS Policy (OIDP), Office of
Minority Health (OMH), Office of
Population Affairs (OPA), Office of
Research Integrity (ORI), and Office on
Women’s Health (OWH). Another OASH
component, the Office of Regional
Health Operations (ORHO), which
includes ten Regional Offices covering
all states and territories of the United
States and three independent states in
the Pacific, through its coordinating
function will also be involved in the
OASH Grants Workshops.
Consistent with each office’s mission
and applicable statutory authority, the
OASH Grants Workshops aim to build
capacity among potential grant
applicants and grant recipients in
related areas such as applying for and
managing grants and cooperative
agreements (collectively grants)
awarded under the programs listed by
Assistance Listing number below:
• 93.007 Public Awareness Campaigns
on Embryo Adoption
• 93.085 Research on Research Integrity
• 93.088 Advancing System
Improvements for Key Issues in
Women’s Health
E:\FR\FM\21NON1.SGM
21NON1
Federal Register / Vol. 87, No. 223 / Monday, November 21, 2022 / Notices
lotter on DSK11XQN23PROD with NOTICES1
• 93.137 Community Programs to
Improve Minority Health Grant
Program
• 93.217 Family Planning Services
• 93.260 Family Planning Personnel
Training
• 93.297 Teenage Pregnancy Prevention
Program
• 98.343 Public Health Service
Evaluation Funds
• 93.344 Research, Monitoring and
Outcomes Definitions for Vaccine
Safety
• 93.974 Family Planning Service
Delivery Improvement Research
Grants
Full Assistance Listing descriptions
are published and updated annually on
https://sam.gov. Co-sponsors will work
with OASH/GAM staff to jointly
develop an event. Both OASH and the
co-sponsor must contribute
substantively to the development of the
event.
OASH Grants Workshops may be
convened over one to three days;
conducted virtually, in-person, or in a
hybrid format (virtual and in-person).
Depending on the workshop format and
scope, a workshop may typically
accommodate between 100 and 500
attendees.
Co-sponsors can charge registration
fees to recover costs associated with the
events; however, co-sponsors may not
set registration fees at an amount higher
than necessary to recover related event
expenses. Further, co-sponsors are
solely responsible for collecting and
handling any registration fees collected.
Eligibility for Co-Sponsorship: The cosponsoring entity must have a
demonstrated interest and experience in
building capacity among potential grant
applicants and grant recipients,
particularly with respect to programs
supported by GAM. The co-sponsoring
entity must participate substantively in
the co-sponsored activity, not just
provide funding, logistical services, or
other material support.
Each potential co-sponsorship’s
expression of interest shall describe:
(1) The entity’s interest in building
capacity among potential grant
applicants and grant recipients,
(2) The entity’s prior experience and
current readiness to undertake the
responsibilities described above,
(3) The type of event(s) that the entity
is interested in co-sponsoring with
GAM,
(4) Facilities and/or virtual platforms
available for the event(s), and
(5) Any current constraints with
respect to dates or facilities.
The type of event may be a special
topic of mutual interest with one or
VerDate Sep<11>2014
21:25 Nov 18, 2022
Jkt 259001
70849
more of the aforementioned GAM
supported program offices and may be
developed jointly.
The expression of interest should be
a bulleted outline, no more than two
pages in length, single-spaced, and 11point font. An entity may submit an
expression of interest individually or
jointly with other entities describing
their relative contributions.
Evaluation Criteria: After engaging in
exploratory discussions with potential
co-sponsors that respond to this notice,
the following considerations will be
used by HHS officials, as appropriate
and relevant, to select the co-sponsor(s):
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
• Qualifications and capability to fulfill
co-sponsorship responsibilities
• Suitability of the location of the
proposed OASH Grants Workshops in
terms of the overall geographical
distribution of OASH Grants
Workshops
• Potential for reaching, generating, and
engaging an adequate number of
attendees who may be potential grant
applicants and grant recipients
• Availability and description of
facilities and resources needed to
support the OASH Grants Workshop
• Availability of administrative support
for the logistics of hosting such OASH
Grants Workshops
Dated: November 16, 2022.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
These duties will be outlined in a cosponsorship agreement with GAM and
the sponsoring program office(s) that
will set forth the details of the cosponsored activity, including the
requirements that any fees collected by
the co-sponsor shall be limited to the
amount necessary to cover the cosponsor’s related event expenses. This
co-sponsorship agreement does not
represent an endorsement by HHS,
OASH, GAM or its supported program
office(s) of an individual co-sponsor’s
policies, positions, or activities.
Additionally, this agreement will not
affect any determination concerning
activities by the co-sponsors that are
regulated by GAM’s grant-supporting
offices.
Dated: November 14, 2022.
Scott J. Moore,
Director, Grants and Acquisitions
Management Division, Office of the Assistant
Secretary for Health.
[FR Doc. 2022–25259 Filed 11–18–22; 8:45 am]
BILLING CODE 4150–28–P
PO 00000
Frm 00080
Fmt 4703
Sfmt 4703
National Institutes of Health
National Library of Medicine;
Cancellation of Meeting
Notice is hereby given of the
cancellation of the National Library of
Medicine Special Emphasis Panel,
March 16, 2023, 11 a.m. to 3 p.m.,
Virtual Meeting, which was published
in the Federal Register on October 6,
2022, 87 FR 193 Page Number 60696.
This notice is being amended to
announce that the meeting is cancelled
and will not be rescheduled.
[FR Doc. 2022–25317 Filed 11–18–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; RFA–DK–22–004
NIDDK Partnerships with Professional
Societies to Enhance Scientific Workforce
Diversity and Promote Scientific Leadership.
Date: December 16, 2022.
Time: 2:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute of Diabetes and Digestive
and Kidney Diseases, 2 Democracy, 6707
Democracy Blvd., Bethesda, MD 20892
(Virtual Meeting).
Contact Person: John F. Connaughton,
Ph.D., Chief, Scientific Review Branch,
Review Branch, DEA, Niddk National
Institutes of Health, Room 7007, 6707
E:\FR\FM\21NON1.SGM
21NON1
]]>Agencies
[Federal Register Volume 87, Number 223 (Monday, November 21, 2022)]
[Notices]
[Pages 70848-70849]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-25259]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Office of the Assistant Secretary for Health; Opportunity To Co-
Sponsor OASH-Supported Grantee Workshops
AGENCY: Office of the Assistant Secretary for Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Grants and Acquisitions Management Division (GAM) in the
Office of the Assistant Secretary for Health (OASH), in conjunction
with the grant making program offices it supports, announces the
opportunity for non-federal public and private sector entities to co-
sponsor OASH-supported grants workshops (OASH Grants Workshops).
Potential co-sponsors must have a demonstrated interest and experience
in building capacity among potential grant applicants and grant
recipients. Potential co-sponsors must be willing to participate
substantively in the co-sponsored activity. Expressions of interest for
co-sponsorships of OASH Grants Workshops are received throughout the
year at the email address below. OASH intends to co-sponsor a limited
number of workshops with other entities each year. Expressions of
interest are being received for OASH Grants Workshops that will take
place in the next fiscal year (October 2022 through September 2023) or
beyond. Expressions of interest for co-sponsorships should be sent by
email to [email protected] with ``Co-sponsorship for OASH-supported
Grants Workshops'' in the subject field or by mail to Duane Barlow,
Grants Branch Chief, OASH, Grants and Acquisitions Management Division,
at 1101 Wootton Parkway, Plaza Level, Rockville, MD 20852.
FOR FURTHER INFORMATION CONTACT: Duane Barlow, Grants Branch Chief,
OASH, Grants and Acquisitions Management Division, 1101 Wootton
Parkway, Plaza Level, Rockville, MD 20852; or via phone (240) 453-8822.
SUPPLEMENTARY INFORMATION: The OASH Grants and Acquisitions Management
(GAM) Division oversees, administers, and supports grant-making
activities of public health offices on behalf of the Secretary of the
U.S. Department of Health and Human Services (HHS). The grant-making
program offices that GAM supports include: the Office of Infectious
Disease and HIV/AIDS Policy (OIDP), Office of Minority Health (OMH),
Office of Population Affairs (OPA), Office of Research Integrity (ORI),
and Office on Women's Health (OWH). Another OASH component, the Office
of Regional Health Operations (ORHO), which includes ten Regional
Offices covering all states and territories of the United States and
three independent states in the Pacific, through its coordinating
function will also be involved in the OASH Grants Workshops.
Consistent with each office's mission and applicable statutory
authority, the OASH Grants Workshops aim to build capacity among
potential grant applicants and grant recipients in related areas such
as applying for and managing grants and cooperative agreements
(collectively grants) awarded under the programs listed by Assistance
Listing number below:
93.007 Public Awareness Campaigns on Embryo Adoption
93.085 Research on Research Integrity
93.088 Advancing System Improvements for Key Issues in Women's
Health
[[Page 70849]]
93.137 Community Programs to Improve Minority Health Grant
Program
93.217 Family Planning Services
93.260 Family Planning Personnel Training
93.297 Teenage Pregnancy Prevention Program
98.343 Public Health Service Evaluation Funds
93.344 Research, Monitoring and Outcomes Definitions for
Vaccine Safety
93.974 Family Planning Service Delivery Improvement Research
Grants
Full Assistance Listing descriptions are published and updated
annually on https://sam.gov. Co-sponsors will work with OASH/GAM staff
to jointly develop an event. Both OASH and the co-sponsor must
contribute substantively to the development of the event.
OASH Grants Workshops may be convened over one to three days;
conducted virtually, in-person, or in a hybrid format (virtual and in-
person). Depending on the workshop format and scope, a workshop may
typically accommodate between 100 and 500 attendees.
Co-sponsors can charge registration fees to recover costs
associated with the events; however, co-sponsors may not set
registration fees at an amount higher than necessary to recover related
event expenses. Further, co-sponsors are solely responsible for
collecting and handling any registration fees collected.
Eligibility for Co-Sponsorship: The co-sponsoring entity must have
a demonstrated interest and experience in building capacity among
potential grant applicants and grant recipients, particularly with
respect to programs supported by GAM. The co-sponsoring entity must
participate substantively in the co-sponsored activity, not just
provide funding, logistical services, or other material support.
Each potential co-sponsorship's expression of interest shall
describe:
(1) The entity's interest in building capacity among potential
grant applicants and grant recipients,
(2) The entity's prior experience and current readiness to
undertake the responsibilities described above,
(3) The type of event(s) that the entity is interested in co-
sponsoring with GAM,
(4) Facilities and/or virtual platforms available for the event(s),
and
(5) Any current constraints with respect to dates or facilities.
The type of event may be a special topic of mutual interest with
one or more of the aforementioned GAM supported program offices and may
be developed jointly.
The expression of interest should be a bulleted outline, no more
than two pages in length, single-spaced, and 11-point font. An entity
may submit an expression of interest individually or jointly with other
entities describing their relative contributions.
Evaluation Criteria: After engaging in exploratory discussions with
potential co-sponsors that respond to this notice, the following
considerations will be used by HHS officials, as appropriate and
relevant, to select the co-sponsor(s):
Qualifications and capability to fulfill co-sponsorship
responsibilities
Suitability of the location of the proposed OASH Grants
Workshops in terms of the overall geographical distribution of OASH
Grants Workshops
Potential for reaching, generating, and engaging an adequate
number of attendees who may be potential grant applicants and grant
recipients
Availability and description of facilities and resources
needed to support the OASH Grants Workshop
Availability of administrative support for the logistics of
hosting such OASH Grants Workshops
These duties will be outlined in a co-sponsorship agreement with
GAM and the sponsoring program office(s) that will set forth the
details of the co-sponsored activity, including the requirements that
any fees collected by the co-sponsor shall be limited to the amount
necessary to cover the co-sponsor's related event expenses. This co-
sponsorship agreement does not represent an endorsement by HHS, OASH,
GAM or its supported program office(s) of an individual co-sponsor's
policies, positions, or activities. Additionally, this agreement will
not affect any determination concerning activities by the co-sponsors
that are regulated by GAM's grant-supporting offices.
Dated: November 14, 2022.
Scott J. Moore,
Director, Grants and Acquisitions Management Division, Office of the
Assistant Secretary for Health.
[FR Doc. 2022-25259 Filed 11-18-22; 8:45 am]
BILLING CODE 4150-28-P
